We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$334M
AUM Growth
+$12.7M
Cap. Flow
-$8.55M
Cap. Flow %
-2.56%
Top 10 Hldgs %
34.49%
Holding
217
New
11
Increased
36
Reduced
117
Closed
8

Top Buys

Rank Stock Value
1
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$711K
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$510K
3
AMN icon
AMN Healthcare
AMN
+$488K
4
APD icon
Air Products & Chemicals
APD
+$482K
5
DUK icon
Duke Energy
DUK
+$459K

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$1.2M
2
MSFT icon
Microsoft
MSFT
+$1.11M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.04M
4
ABBV icon
AbbVie
ABBV
+$1.02M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$933K

Sector Composition

Rank Sector Weight
1 Healthcare 18.1%
2 Technology 16.4%
3 Financials 12.44%
4 Industrials 9.27%
5 Communication Services 6.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYM icon
151
Vanguard High Dividend Yield ETF
VYM
$81.1B
$344K 0.1%
2,843
-400
-12% -$45.8K
COP icon
152
ConocoPhillips
COP
$147B
$335K 0.1%
2,634
– –
MMM icon
153
3M
MMM
$91.3B
$335K 0.1%
3,779
-333
-8% -$27.6K
T icon
154
AT&T
T
$159B
$331K 0.1%
18,810
– –
ILMN icon
155
Illumina
ILMN
$31B
$324K 0.1%
2,428
-70
-3% -$9.38K
AZN icon
156
AstraZeneca
AZN
$264B
$324K 0.1%
2,390
– –
PAYX icon
157
Paychex
PAYX
$41.6B
$323K 0.1%
2,630
-100
-4% -$12.1K
CBOE icon
158
Cboe Global Markets
CBOE
$32.4B
$319K 0.1%
1,738
– –
QQQ icon
159
Invesco QQQ Trust
QQQ
$455B
$318K 0.1%
717
-32
-4% -$13.7K
SAM icon
160
Boston Beer
SAM
$1.9B
$317K 0.1%
1,042
+124
+14% +$41.4K
PCTY icon
161
Paylocity
PCTY
$7.35B
$315K 0.09%
1,835
– –
CHD icon
162
Church & Dwight Co
CHD
$23.5B
$311K 0.09%
2,980
-40
-1% -$4K
ALB icon
163
Albemarle
ALB
$13.9B
$310K 0.09%
2,351
+298
+15% +$36.7K
VMC icon
164
Vulcan Materials
VMC
$34.8B
$304K 0.09%
1,115
+136
+14% +$33.5K
SF
165
Stifel
SF
$12.6B
$304K 0.09%
5,835
-383
-6% -$18.9K
EMR icon
166
Emerson Electric
EMR
$84B
$303K 0.09%
2,673
-65
-2% -$6.68K
IEFA icon
167
iShares Core MSCI EAFE ETF
IEFA
$191B
$300K 0.09%
4,045
– –
UL icon
168
Unilever
UL
$137B
$298K 0.09%
5,281
– –
NEM icon
169
Newmont
NEM
$98.9B
$288K 0.09%
8,038
+1,965
+32% +$67.7K
DELL icon
170
Dell
DELL
$264B
$278K 0.08%
+2,435
New +$227K
WAB icon
171
Wabtec
WAB
$49.4B
$270K 0.08%
1,855
-238
-11% -$32.2K
OGN icon
172
Organon & Co
OGN
$3.56B
$267K 0.08%
14,226
-3,858
-21% -$66.2K
BA icon
173
Boeing
BA
$171B
$265K 0.08%
1,371
+232
+20% +$47.7K
TSLA icon
174
Tesla
TSLA
$1.23T
$264K 0.08%
1,502
-66
-4% -$12.9K
TROW icon
175
T. Rowe Price
TROW
$24.1B
$264K 0.08%
2,165
– –
5 6
7
8 9

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Roberts, Glore & Co held 217 positions worth $334M, up 4% from $321M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Roberts, Glore & Co's Q1 2024 filing shows 11 new, 36 increased, 117 reduced and 8 closed positions. Its largest new stake was AMN Healthcare: 7,170 shares worth $448K. The largest sale was Splunk Inc, an estimated $1.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Roberts, Glore & Co's largest Q1 2024 buy was AMN Healthcare: 7,170 shares worth $448K.
  • Roberts, Glore & Co added most to Vanguard Tax-Exempt Bond Index Fund in Q1 2024, an estimated $711K increase.
  • Roberts, Glore & Co's biggest Q1 2024 reduction was Microsoft, cutting an estimated $1.11M.
  • Roberts, Glore & Co fully exited Splunk Inc in Q1 2024, selling an estimated $1.2M.
  • Roberts, Glore & Co's ten largest holdings make up 34% of its $334M portfolio in Q1 2024.
  • Roberts, Glore & Co opened 11 new positions and closed 8 in Q1 2024.
  • Roberts, Glore & Co's portfolio value rose 4% quarter-over-quarter to $334M.

Based on Roberts, Glore & Co's 13F filing for Q1 2024, filed 9 May 2024.